Relevance of plasma protein binding to antiviral activity and clinical efficacy of inhibitors of human immunodeficiency virus protease

被引：25

作者：

Bilello, JA

Drusano, GL

机构：

来源：

JOURNAL OF INFECTIOUS DISEASES | 1996年 / 173卷 / 06期

关键词：

D O I：

10.1093/infdis/173.6.1524

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1524 / 1525

页数：2

共 10 条

[1] REDUCTION OF THE IN-VITRO ACTIVITY OF A77003, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE, BY HUMAN SERUM ALPHA(1) ACID GLYCOPROTEIN [J].

BILELLO, JA ;

BILELLO, PA ;

PRICHARD, M ;

ROBINS, T ;

DRUSANO, GL .

JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :546-551

[2] EFFICACY OF CONSTANT INFUSION OF A-77003, AN INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE, IN LIMITING ACUTE HIV-1 INFECTION IN-VITRO [J].

BILELLO, JA ;

BILELLO, PA ;

KORT, JJ ;

DUDLEY, MN ;

LEONARD, J ;

DRUSANO, GL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2523-2527

[3]

BILELLO JA, 1995, 2 NAT C HUM RETR REL

[4] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].

CONDRA, JH ;

SCHLEIF, WA ;

BLAHY, OM ;

GABRYELSKI, LJ ;

GRAHAM, DJ ;

QUINTERO, JC ;

RHODES, A ;

ROBBINS, HL ;

ROTH, E ;

SHIVAPRAKASH, M ;

TITUS, D ;

YANG, T ;

TEPPLER, H ;

SQUIRES, KE ;

DEUTSCH, PJ ;

EMINI, EA .

NATURE, 1995, 374 (6522) :569-571

[5] A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE [J].

DANNER, SA ;

CARR, A ;

LEONARD, JM ;

LEHMAN, LM ;

GUDIOL, F ;

GONZALES, J ;

RAVENTOS, A ;

RUBIO, R ;

BOUZA, E ;

PINTADO, V ;

AGUADO, AG ;

DELOMAS, JG ;

DELGADO, R ;

BORLEFFS, JCC ;

HSU, A ;

VALDES, JM ;

BOUCHER, CAB ;

COOPER, DA ;

GIMENO, C ;

CLOTET, B ;

TOR, J ;

FERRER, E ;

MARTINEZ, PL ;

MORENO, S ;

ZANCADA, G ;

ALCAMI, J ;

NORIEGA, AR ;

PULIDO, F ;

GLASSMAN, HN .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1528-1533

[6] EFFECT OF SATURABLE SERUM-PROTEIN BINDING ON THE PHARMACOKINETICS OF UNBOUND CEFONICID IN HUMANS [J].

DUDLEY, MN ;

SHYU, WC ;

NIGHTINGALE, CH ;

QUINTILIANI, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) :565-569

[7] A RANDOMIZED TRIAL OF THE ACTIVITY AND SAFETY OF RO-24-7429 (TAT ANTAGONIST) VERSUS NUCLEOSIDE FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].

HAUBRICH, RH ;

FLEXNER, C ;

LEDERMAN, MM ;

HIRSCH, M ;

PETTINELLI, CP ;

GINSBERG, R ;

LIETMAN, P ;

HAMZEH, FM ;

SPECTOR, SA ;

RICHMAN, DD ;

HAMMER, S ;

COOLEY, T ;

GULICK, R ;

SULLIVAN, M ;

SPINA, C ;

FRASER, A ;

LATHEY, J ;

BASSIAKOS, Y ;

CHANCE, M ;

DROBNES, C ;

CORUELL, E ;

GRUE, L ;

RAINES, C ;

KUWAHARA, S ;

MCPHERSON, J .

JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05) :1246-1252

[8] WEAK BINDING OF VX-478 TO HUMAN PLASMA-PROTEINS AND IMPLICATIONS FOR ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS THERAPY [J].

LIVINGSTON, DJ ;

PAZHANISAMY, S ;

PORTER, DJT ;

PARTALEDIS, JA ;

TUNG, RD ;

PAINTER, GR .

JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05) :1238-1245

[9] EFFECT OF PROTEIN-BINDING ON ANTIBIOTIC-ACTIVITY INVIVO [J].

MERRIKIN, DJ ;

BRIANT, J ;

ROLINSON, GN .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (03) :233-238

[10]

STEIN DS, 1996, IN PRESS AIDS, P10

← 1 →